Published in Cancer Res on April 06, 2012
Nanoscale changes in chromatin organization represent the initial steps of tumorigenesis: a transmission electron microscopy study. BMC Cancer (2014) 1.29
Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology. Oncogene (2013) 1.23
Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression. Mod Pathol (2014) 1.16
Multifocal epithelial tumors and field cancerization: stroma as a primary determinant. J Clin Invest (2014) 1.10
Advances in biophotonics detection of field carcinogenesis for colon cancer risk stratification. J Cancer (2013) 1.06
Insights into the field carcinogenesis of ovarian cancer based on the nanocytology of endocervical and endometrial epithelial cells. Int J Cancer (2013) 0.97
Nanocytological field carcinogenesis detection to mitigate overdiagnosis of prostate cancer: a proof of concept study. PLoS One (2015) 0.94
High-speed spectral nanocytology for early cancer screening. J Biomed Opt (2013) 0.92
Biological mechanisms underlying structural changes induced by colorectal field carcinogenesis measured with low-coherence enhanced backscattering (LEBS) spectroscopy. PLoS One (2013) 0.87
Network signatures of nuclear and cytoplasmic density alterations in a model of pre and postmetastatic colorectal cancer. J Biomed Opt (2014) 0.85
Enriching the molecular definition of the airway "field of cancerization:" establishing new paradigms for the patient at risk for lung cancer. Cancer Prev Res (Phila) (2012) 0.84
Evidence-based Guidelines for Precision Risk Stratification-Based Screening (PRSBS) for Colorectal Cancer: Lessons learned from the US Armed Forces: Consensus and Future Directions. J Cancer (2013) 0.82
Spectroscopic applications in gastrointestinal endoscopy. Clin Gastroenterol Hepatol (2012) 0.82
Nuclear Nano-architecture Markers of Gastric Cardia and Upper Squamous Esophagus Detect Esophageal Cancer "Field Effect". J Cancer (2013) 0.81
Nanocytology vs. Immunohistochemistry of Intestinal Colonocytes to Assess the Risk of Colon Cancer based on Field Cancerization - A Preliminary Report. J Cancer (2013) 0.81
Nano-architectural alterations in mucus layer fecal colonocytes in field carcinogenesis: potential for screening. Cancer Prev Res (Phila) (2013) 0.80
Diagnostics: Playing detective. Nature (2012) 0.80
Nanometer-scale sizing accuracy of particle suspensions on an unmodified cell phone using elastic light scattering. PLoS One (2012) 0.80
Higher Order Chromatin Modulator Cohesin SA1 Is an Early Biomarker for Colon Carcinogenesis: Race-Specific Implications. Cancer Prev Res (Phila) (2016) 0.78
Field cancerisation in colorectal cancer: a new frontier or pastures past? World J Gastroenterol (2015) 0.77
Procedures for risk-stratification of lung cancer using buccal nanocytology. Biomed Opt Express (2016) 0.76
The Global Relationship between Chromatin Physical Topology, Fractal Structure, and Gene Expression. Sci Rep (2017) 0.76
Automated Cell Selection Using Support Vector Machine for Application to Spectral Nanocytology. Biomed Res Int (2016) 0.75
Review of interferometric spectroscopy of scattered light for the quantification of subdiffractional structure of biomaterials. J Biomed Opt (2017) 0.75
APC gene testing for familial adenomatosis polyposis. JAMA (2012) 0.75
Optical Phase Measurements of Disorder Strength Link Microstructure to Cell Stiffness. Biophys J (2017) 0.75
Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin (2011) 30.81
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology (2008) 15.86
Hereditary colorectal cancer. N Engl J Med (2003) 11.86
Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med (2008) 9.32
Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med (2004) 6.42
Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res (1998) 4.39
Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet (1999) 4.16
Prevalence of clinically important histology in small adenomas. Clin Gastroenterol Hepatol (2006) 3.79
A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology (2005) 2.71
Flexible sigmoidoscopy and the changing distribution of colorectal cancer: implications for screening. Gut (2001) 2.36
Optical methodology for detecting histologically unapparent nanoscale consequences of genetic alterations in biological cells. Proc Natl Acad Sci U S A (2008) 2.33
Partial-wave microscopic spectroscopy detects subwavelength refractive index fluctuations: an application to cancer diagnosis. Opt Lett (2009) 2.04
Detection of proximal adenomatous polyps with screening sigmoidoscopy: a systematic review and meta-analysis of screening colonoscopy. Arch Intern Med (2003) 2.02
Alteration of gene expression in normal-appearing colon mucosa of APC(min) mice and human cancer patients. Cancer Res (2004) 1.95
Optical detection of buccal epithelial nanoarchitectural alterations in patients harboring lung cancer: implications for screening. Cancer Res (2010) 1.94
Nanoscale cellular changes in field carcinogenesis detected by partial wave spectroscopy. Cancer Res (2009) 1.91
Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840,149 screening colonoscopies. Gut (2007) 1.79
Epigenetic field for cancerization. J Biochem Mol Biol (2007) 1.73
Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis. Gastroenterology (2004) 1.49
Proteomic analysis reveals field-wide changes in protein expression in the morphologically normal mucosa of patients with colorectal neoplasia. Cancer Res (2006) 1.48
Rectal epithelial cell proliferation patterns as predictors of adenomatous colorectal polyp recurrence. Gut (1993) 1.39
Oral epithelium as a surrogate tissue for assessing smoking-induced molecular alterations in the lungs. Cancer Prev Res (Phila) (2008) 1.32
Role of cytoskeleton in controlling the disorder strength of cellular nanoscale architecture. Biophys J (2010) 1.30
Underuse of colorectal cancer screening in a cohort of Medicare beneficiaries. Cancer (2008) 1.29
Field defects in progression to gastrointestinal tract cancers. Cancer Lett (2007) 1.28
A bile acid-induced apoptosis assay for colon cancer risk and associated quality control studies. Cancer Res (1999) 1.24
Karyometry of the colonic mucosa. Cancer Epidemiol Biomarkers Prev (2007) 1.20
Surrogate anatomic/functional sites for evaluating cancer risk: an extension of the field effect. Clin Cancer Res (1999) 1.12
The influence of chromosome density variations on the increase in nuclear disorder strength in carcinogenesis. Phys Biol (2011) 1.07
Colon cancer screening: the good, the bad, and the ugly. Arch Intern Med (2006) 1.02
Characterization of human colorectal mucosa, polyps, and cancers by means of computerized morphonuclear image analyses. Cancer (1990) 0.94
Current status and prospects of clinical proteomics studies on detection of colorectal cancer: hopes and fears. World J Gastroenterol (2006) 0.93
Optical measurement of rectal microvasculature as an adjunct to flexible sigmoidosocopy: gender-specific implications. Cancer Prev Res (Phila) (2010) 0.93
Aberrant crypt foci as precursors of the dysplasia-carcinoma sequence in patients with ulcerative colitis. Clin Cancer Res (2008) 0.91
Risk of colon cancer in hereditary non-polyposis colorectal cancer patients as predicted by fuzzy modeling: Influence of smoking. World J Gastroenterol (2006) 0.91
A proteomic study of resistance to deoxycholate-induced apoptosis. Carcinogenesis (2004) 0.90
Quantification of nanoscale density fluctuations using electron microscopy: Light-localization properties of biological cells. Appl Phys Lett (2010) 0.85
Epidemiology of inflammatory bowel disease and overview of pathogenesis. Med Health R I (2009) 0.84
Expression and functional proteomics studies in colorectal cancer. Pathol Res Pract (2004) 0.84
Data representation and reduction for chromatin texture in nuclei from premalignant prostatic, esophageal, and colonic lesions. Cytometry (2000) 0.84
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology (2008) 15.86
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin (2008) 12.90
Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology (2012) 8.51
Quality indicators for colonoscopy. Am J Gastroenterol (2006) 6.51
A retrograde-viewing device improves detection of adenomas in the colon: a prospective efficacy evaluation (with videos). Gastrointest Endosc (2009) 5.38
Endoscopist can be more powerful than age and male gender in predicting adenoma detection at colonoscopy. Am J Gastroenterol (2007) 4.62
Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology (2006) 4.57
Quality indicators for colonoscopy. Gastrointest Endosc (2014) 4.17
Complications following colonoscopy with anesthesia assistance: a population-based analysis. JAMA Intern Med (2013) 4.07
Effect of screening colonoscopy on colorectal cancer incidence and mortality. Clin Gastroenterol Hepatol (2009) 3.96
Prophylactic clip closure reduced the risk of delayed postpolypectomy hemorrhage: experience in 277 clipped large sessile or flat colorectal lesions and 247 control lesions. Gastrointest Endosc (2013) 3.72
Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA (2007) 3.62
Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia. Cell (2007) 3.58
Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study. J Clin Oncol (2008) 3.54
Associations between the age at diagnosis and location of colorectal cancer and the use of alcohol and tobacco: implications for screening. Arch Intern Med (2006) 3.32
Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin (2006) 3.21
Incidence and predictors of "late" recurrences after endoscopic piecemeal resection of large sessile adenomas. Gastrointest Endosc (2009) 2.99
Genetic and environmental risk assessment and colorectal cancer screening in an average-risk population: a randomized trial. Ann Intern Med (2014) 2.89
Maximizing control of tip deflection with sound ergonomics: the "left hand shaft grip". Gastrointest Endosc (2007) 2.82
Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med (2008) 2.74
Nonscalar elastic light scattering from continuous random media in the Born approximation. Opt Lett (2009) 2.59
The American Society for Gastrointestinal Endoscopy PIVI (Preservation and Incorporation of Valuable Endoscopic Innovations) on real-time endoscopic assessment of the histology of diminutive colorectal polyps. Gastrointest Endosc (2011) 2.51
Upper endoscopy for gastroesophageal reflux disease: best practice advice from the clinical guidelines committee of the American College of Physicians. Ann Intern Med (2012) 2.47
High-definition chromocolonoscopy vs. high-definition white light colonoscopy for average-risk colorectal cancer screening. Am J Gastroenterol (2010) 2.47
Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update. Int J Cancer (2006) 2.41
Cellular organization and substructure measured using angle-resolved low-coherence interferometry. Biophys J (2002) 2.40
Efficacy of bispectral monitoring as an adjunct to nurse-administered propofol sedation for colonoscopy: a randomized controlled trial. Am J Gastroenterol (2006) 2.39
A genome wide linkage search for breast cancer susceptibility genes. Genes Chromosomes Cancer (2006) 2.35
Propofol alone titrated to deep sedation versus propofol in combination with opioids and/or benzodiazepines and titrated to moderate sedation for colonoscopy. Am J Gastroenterol (2006) 2.35
Spectroscopic detection and evaluation of morphologic and biochemical changes in early human oral carcinoma. Cancer (2003) 2.35
Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy. Clin Gastroenterol Hepatol (2010) 2.34
Optical methodology for detecting histologically unapparent nanoscale consequences of genetic alterations in biological cells. Proc Natl Acad Sci U S A (2008) 2.33
Miss rate of right-sided colon examination during colonoscopy defined by retroflexion: an observational study. Gastrointest Endosc (2011) 2.27
High colonoscopic prevalence of proximal colon serrated polyps in average-risk men and women. Gastrointest Endosc (2011) 2.22
Distinguishing right from left colon by the pattern of gene expression. Cancer Epidemiol Biomarkers Prev (2003) 2.22
Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging. J Clin Oncol (2011) 2.17
Is internal massage superior to external massage for patients suffering a cardiac arrest after cardiac surgery? Interact Cardiovasc Thorac Surg (2007) 2.17
Endoscopic prediction of deep submucosal invasive carcinoma: validation of the narrow-band imaging international colorectal endoscopic (NICE) classification. Gastrointest Endosc (2013) 2.16
International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. Int J Cancer (2008) 2.13
Validation of a simple classification system for endoscopic diagnosis of small colorectal polyps using narrow-band imaging. Gastroenterology (2012) 2.11
ASGE Technology Committee systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting real-time endoscopic assessment of the histology of diminutive colorectal polyps. Gastrointest Endosc (2015) 2.11
Optical markers in duodenal mucosa predict the presence of pancreatic cancer. Clin Cancer Res (2007) 2.10
Quality indicators for colonoscopy. Am J Gastroenterol (2014) 2.06
Partial-wave microscopic spectroscopy detects subwavelength refractive index fluctuations: an application to cancer diagnosis. Opt Lett (2009) 2.04
Trimodal spectroscopy for the detection and characterization of cervical precancers in vivo. Am J Obstet Gynecol (2002) 2.02
Optical detection of buccal epithelial nanoarchitectural alterations in patients harboring lung cancer: implications for screening. Cancer Res (2010) 1.94
The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype. Am J Hum Genet (2003) 1.93
Nanoscale cellular changes in field carcinogenesis detected by partial wave spectroscopy. Cancer Res (2009) 1.91
Propofol versus midazolam/meperidine for outpatient colonoscopy: administration by nurses supervised by endoscopists. Gastrointest Endosc (2002) 1.90
Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study. Lancet Oncol (2007) 1.89
Cap-fitted colonoscopy: a randomized, tandem colonoscopy study of adenoma miss rates. Gastrointest Endosc (2010) 1.87
Elastic backscattering spectroscopic microscopy. Opt Lett (2005) 1.84
Differentiating adenomas from hyperplastic colorectal polyps: narrow-band imaging can be learned in 20 minutes. Gastrointest Endosc (2010) 1.80
Management of bleeding GI tumors. Gastrointest Endosc (2010) 1.79
Four-dimensional elastic light-scattering fingerprints as preneoplastic markers in the rat model of colon carcinogenesis. Gastroenterology (2004) 1.79
Accurate classification of MLH1/MSH2 missense variants with multivariate analysis of protein polymorphisms-mismatch repair (MAPP-MMR). Hum Mutat (2008) 1.76
Spectroscopic microvascular blood detection from the endoscopically normal colonic mucosa: biomarker for neoplasia risk. Gastroenterology (2008) 1.73
Facilitating informed decisions regarding microsatellite instability testing among high-risk individuals diagnosed with colorectal cancer. J Clin Oncol (2010) 1.69
Position statement: Nonanesthesiologist administration of propofol for GI endoscopy. Gastroenterology (2009) 1.67
A resect and discard strategy would improve cost-effectiveness of colorectal cancer screening. Clin Gastroenterol Hepatol (2010) 1.63
Surfaced-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) differentiation of serum protein profiles of BRCA-1 and sporadic breast cancer. Ann Surg Oncol (2004) 1.63
Colon polyp retrieval after cold snaring. Gastrointest Endosc (2005) 1.62
Coherent backscattering spectroscopy. Opt Lett (2004) 1.62
Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC). Genes Chromosomes Cancer (2005) 1.61
Prospective description of coughing, hemodynamic changes, and oxygen desaturation during endoscopic sedation. Dig Dis Sci (2012) 1.61
Determination of particle size by using the angular distribution of backscattered light as measured with low-coherence interferometry. J Opt Soc Am A Opt Image Sci Vis (2002) 1.61
Occult tumor burden predicts disease recurrence in lymph node-negative colorectal cancer. Clin Cancer Res (2011) 1.59
A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagus. Gastroenterology (2012) 1.58
Tissue self-affinity and polarized light scattering in the born approximation: a new model for precancer detection. Phys Rev Lett (2006) 1.58
Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group. J Clin Oncol (2008) 1.57
Prospective analysis of association between use of statins or other lipid-lowering agents and colorectal cancer risk. Ann Epidemiol (2011) 1.57
Association between rectal optical signatures and colonic neoplasia: potential applications for screening. Cancer Res (2009) 1.53
Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriers. Int J Cancer (2006) 1.53
Colonoscopy surveillance after polypectomy and colorectal cancer resection. Am Fam Physician (2008) 1.52
Treatment of distal radius fractures. J Am Acad Orthop Surg (2010) 1.51
Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome. Obstet Gynecol (2005) 1.50
Accuracy of the Born approximation in calculating the scattering coefficient of biological continuous random media. Opt Lett (2009) 1.50
Chemoprevention of colorectal cancer by aspirin: a cost-effectiveness analysis. Gastroenterology (2002) 1.49
Emergence of T cells that recognize nonpolymorphic antigens during graft-versus- host disease. Blood (2012) 1.48
Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations. Arch Intern Med (2004) 1.48
Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management. Clin Cancer Res (2005) 1.46